glp-1 pregnancy risk From JAMA: #GLP-1 receptor agonist exposure with discontinuation before or during early #pregnancy was associated with greater gestational weight gain and increased of preterm delivery, gestational #diabetes, and hypertensive disorders. https://ja GLP-1 has changed the conversation

Semaglutide GLP-1 is a revolutionary weight loss treatment that typically begins to show noticeable effects within 4 to 6 weeks of use

Rather than focusing on a single mechanism, researchers are exploring a variety of compounds that may provide insight into how cells produce, regulate, and utilize energy

TEER measurement techniques for in vitro barrier model systems

Mounjaro has been approved for type 2 diabetes, while Zepbound focuses on chronic weight management

Four GLP-1s Ozempic, Trulicity, Mounjaro, and Wegovy are represented on the 2023 Top Drugs by Cost list, compared to just two the prior year (see chart below)